Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled trial of amisulpride injection for prevention of postoperative nausea and vomiting
CTR20243863Phase 3Active
- Sponsor
- Shanxi Yanghe Pharmaceutical Technology
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amisulpride, sponsored by Shanxi Yanghe Pharmaceutical Technology. Started Oct 2024; status: active.
02
Drugs
amisulpride
Beyond the preview
Go deeper on CTR20243863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243863.